Immunoglobulin News and Research

RSS

Vaccines that induce mucosal immunity against SARS-CoV-2 are needed

In a recent study posted to the medRxiv* preprint server, researchers in the United Kingdom studied assessed plasma and nasal antibody (Ab) responses induced after a year of coronavirus disease 2019 (COVID-19)-associated hospitalization and the potential boost by subsequent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccinations in the United Kingdom (UK).

12 Sep 2022

The ongoing 2022 West Nile virus transmission season in Italy

A recent article described the seasonal transmission of the West Nile virus in 2022 and compared the human cases reported in June-July 2022 with the reports in 2018.

12 Sep 2022

A direct side-by-side comparison of all available COVID-19 vaccines

In a recent study posted to the medRxiv* preprint server, researchers assessed immune responses to homologous and heterologous coronavirus disease 2019 (COVID-19) vaccine combinations among Córdoba, Spain residents.

11 Sep 2022

The evolution of humoral immune responses over the course of Epstein-Barr virus infection

Researchers explored probable humoral immune mechanisms related to EBV curtailment, besides neutralization, by a systematic emphasis on antibody fragment crystallizable-functional activities over the course of EBV infections.

9 Sep 2022

All SARS-CoV-2 variants neutralized by a potent new antibody

Researchers describe a mouse model used to generate a VH1-2 heavy chain (HC)- and Vκ1-33 light chain (LC)-based recombinant antibody that broadly neutralized all severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants, including the newly emergent Omicron sub-variant BA.5.

9 Sep 2022

Study provides a potential game-changer in assessing treatment response in pancreatic cancer patients

The statistics for pancreatic cancer are sobering. With a five-year survival rate of only 9%, incidence of the most common type, pancreatic ductal adenocarcinoma (PDAC), is growing and projected to be the second cause of cancer deaths by 2030.

8 Sep 2022

Biosynthetic proteins show promise as SARS-CoV-2 antivirals targeting spike protein

Researchers developed an αRep series specific to the RBD of the SARS-CoV-2 S, which could easily adapt to work stably against SARS-CoV-2 variants at a low cost.

8 Sep 2022

How does previous SARS-CoV-2 infection impact the B cell receptor repertoire in response to vaccination?

Researchers evaluated immune responses by B lymphocytes to Pfizer’s severe acute respiratory syndrome coronavirus 2 mRNA vaccine.

8 Sep 2022

How does SARS-CoV-2 infection and vaccination impact human immune memory?

Researchers review current knowledge regarding the generation of immune memory responses and their durability post-infection and vaccination.

7 Sep 2022

How does SARS-CoV-2 infection impact fertility in men?

In a recent review published in the journal Endocrines, researchers summarized existing literature findings on the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on the male reproductive system and fertility.

7 Sep 2022

Techniques used for SARS-CoV-2 detection in body fluids

In a recent review published in the journal Trends in Analytical Chemistry, researchers provided a comprehensive overview of the current techniques used for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection in bodily fluids.

7 Sep 2022

Photocatalyst-based ViraMap platform maps SARS-CoV-2 spike protein interactions on the cell surface

Researchers performed the photocatalytic mapping of the SARS-CoV-2 spike protein-host cell membrane interactions.

7 Sep 2022

Neurological manifestations associated with monkeypox infection

A new study presents current information regarding the neurological presentations and complications of monkeypox infection.

5 Sep 2022

What is the impact of inter-individual heterogeneity on the degree and duration of vaccinal protection against mild and severe COVID-19?

Researchers suggested ways to address heterogeneity in immune responses conferred by COVID-19 vaccines.

5 Sep 2022

Immunoglobulin News and Research

Vaccines that induce mucosal immunity against SARS-CoV-2 are needed

The ongoing 2022 West Nile virus transmission season in Italy

A direct side-by-side comparison of all available COVID-19 vaccines

The evolution of humoral immune responses over the course of Epstein-Barr virus infection

All SARS-CoV-2 variants neutralized by a potent new antibody

Study provides a potential game-changer in assessing treatment response in pancreatic cancer patients

Biosynthetic proteins show promise as SARS-CoV-2 antivirals targeting spike protein

How does previous SARS-CoV-2 infection impact the B cell receptor repertoire in response to vaccination?

How does SARS-CoV-2 infection and vaccination impact human immune memory?

How does SARS-CoV-2 infection impact fertility in men?

Techniques used for SARS-CoV-2 detection in body fluids

Photocatalyst-based ViraMap platform maps SARS-CoV-2 spike protein interactions on the cell surface

Neurological manifestations associated with monkeypox infection

What is the impact of inter-individual heterogeneity on the degree and duration of vaccinal protection against mild and severe COVID-19?

The origins, breadth, and resolution of autoreactivity in severe COVID-19

The effects of SARS-CoV-2 infection on antibody and B-cell responses to a third dose of mRNA vaccination

Molecular fate-mapping of antibodies shows effects of antigenic imprinting

SARS-CoV-2 nucleocapsid antigen levels and patient outcomes

Italian study finds SARS-CoV-2 in clinical samples collected before December 2019

COVID-19 may provoke IgA-associated vasculitis

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News